Biotech 2050 Podcast

Biotech 2050 Podcast

Biotech2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years.

Denne podkasten er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(261)

68. Patient-focused Wet AMD, Nancy Lurker, President & CEO, Said Saim, CTO, EyePoint Pharmaceuticals

68. Patient-focused Wet AMD, Nancy Lurker, President & CEO, Said Saim, CTO, EyePoint Pharmaceuticals

Nancy Lurker: President & Chief Executive Officer Our President, CEO, and a director since September 2016, Ms Lurker has broad-ranging experience in the pharmaceutical industry and a track record of m...

11 Aug 202128min

67. ML protein therapy, Mike Nally, CEO, and Geoff von Maltzahn, Co-Founder, Generate Biomedicines

67. ML protein therapy, Mike Nally, CEO, and Geoff von Maltzahn, Co-Founder, Generate Biomedicines

Mike Nally is the Chief Executive Officer of Generate Biomedicines and a CEO-Partner at Flagship Pioneering. Mike brings significant experience leading global organizations and is passionate about wor...

4 Aug 202136min

66. I’ll take “Wild Rides” for 500, Alex: Biotech Entrepreneur’s Story, Ron Cohen, CEO, Acorda

66. I’ll take “Wild Rides” for 500, Alex: Biotech Entrepreneur’s Story, Ron Cohen, CEO, Acorda

Ron Cohen, M.D. is President, CEO and founder of Acorda Therapeutics, Inc., a public biotechnology company developing therapies for disorders of the nervous system, including multiple sclerosis, Parki...

28 Jul 202140min

65. Patient focused precision oncology, Avanish Vellanki, Cofounder and CEO, Rain Therapeutics

65. Patient focused precision oncology, Avanish Vellanki, Cofounder and CEO, Rain Therapeutics

Avanish Vellanki is passionate about offering cancer patients better treatment options, and he firmly believes that precision oncology strategies are the best manner in which to achieve that goal. He ...

21 Jul 202129min

64. Tech-driven acceleration in clinical trials, Benjamine Liu, Co-founder and CEO, TrialSpark

64. Tech-driven acceleration in clinical trials, Benjamine Liu, Co-founder and CEO, TrialSpark

Benjamine Liu is the co-founder and CEO of TrialSpark, a technology company that is reimagining drug development. Benjamine received his DPhil at Oxford as a Rhodes Scholar, conducting his work with ...

14 Jul 202127min

63. Building a leader in infectious diseases, Ankit Mahadevia, President and CEO, Spero Therapeutics

63. Building a leader in infectious diseases, Ankit Mahadevia, President and CEO, Spero Therapeutics

Ankit Mahadevia is the CEO of Spero Therapeutics and a member of the Board of Directors. He was formerly a Venture Partner in the life sciences group at Atlas Venture, located in Cambridge, MA. In tha...

7 Jul 202138min

62. Tackling autoimmune and allergic disease, Jonathan Rigby, Group CEO, Revolo Biotherapeutics

62. Tackling autoimmune and allergic disease, Jonathan Rigby, Group CEO, Revolo Biotherapeutics

Jonathan Rigby is an experienced CEO with three decades of experience creating value and opportunities for companies in the pharmaceutical, biotech and drug delivery technology industry. He currently ...

23 Jun 202125min

61. Groundbreaking immunology microbe oral therapies, Simba Gill, CEO, Evelo Biosciences

61. Groundbreaking immunology microbe oral therapies, Simba Gill, CEO, Evelo Biosciences

Balkrishan (Simba) Gill, Ph.D. has served as our President, Chief Executive Officer and a member of our Board of Directors since September 2015. Dr. Gill also has served on the board of directors of R...

16 Jun 202140min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
jss
forskningno
sinnsyn
villmarksliv
liberal-halvtime
rss-paradigmepodden
rekommandert
tomprat-med-gunnar-tjomlid
fjellsportpodden
dekodet-2
aldring-og-helse-podden
rss-rekommandert
rss-inn-til-kjernen-med-sunniva-rose
diagnose
vett-og-vitenskap-med-gaute-einevoll
kvinnehelsepodden
rss-overskuddsliv
hva-er-greia-med